|
|
Bright Minds Biosciences Inc
CSE •
Healthcare •
Biotechnology •
Quote as of 09/11/2026 15:48
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeCSE
Market Capitalization870.43 mln
Float7.56 mln
Earnings Date11/14/2026
Relative Strength
20
/ 100
Significantly lagging
Key Fundamentals
EPS-2.84
ROE-14.60
ROIC-14,145
ROA-14.41
Interest Cover-2,336
EBITDA, mln-39.25
EV / EBITDA-17.56
EV / EBIT-17.53
Financial Strength
Piotroski F-Score
3
/ 9
Price to Intrinsic Value6.59
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-6.24% |
31
/ 100
 |
| 1 Month |
-21.38% |
12
/ 100
 |
| 2 Months |
-22.46% |
40
/ 100
 |
| 6 Months |
-17.24% |
56
/ 100
 |
| 1 Year |
148% |
89
/ 100
 |
|
| |
